Abstract
The COVID-19 pandemic mobilized thousands of researchers around the world, who sought to develop technologies to combat its etiological agent, the severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2). Infection with this virus can cause anything from a mild cold to a severe respiratory illness, the latter being accompanied by systemic inflammation with a poor prognosis. On Janua…